U-Ploid is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
U-Ploid is developing a novel therapeutic intended to improve human egg quality in aged eggs. The company is focused on interventions to address age-related decline in oocyte quality.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.